Cashu | Summary

DJI

+0.16%

SPX

+0.32%

IXIC

+0.53%

FTSE

-0.24%

N225

-0.26%

AXJO

-0.08%

HomeWatchlistNewsSignalsPicks

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Instagram YouTube

HomeWatchlistNewsSignalsPicks

DJI

+0.16%

SPX

+0.32%

IXIC

+0.53%

FTSE

-0.24%

N225

-0.26%

AXJO

-0.08%

HomeWatchlistNewsSignalsPicks

Overview

Loading chart...

Join our newsletter to keep up to date with us!

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Instagram YouTube

Overview

Loading chart...

Join our newsletter to keep up to date with us!

Key Stats

Market Cap

738.91M

Dividend Yield

0.00%

P/E Ratio

-6.45

EPS

-0.94

Revenue

Avg. Volume

1.58M

About

What does MNMD do?

Mind Medicine (MindMed) is a clinical-stage biopharmaceutical company based in New York, focused on developing novel treatments for brain health disorders, including MM-120 for anxiety and ADHD, and MM-402 for autism. Founded in 2015, the company employs 57 people and targets neurotransmitter pathways using psychedelics and empathogens.

Sector

💻 Health Care

IPO

CEO

Employees

Headquarters

British Columbia, Canada

Website

http://www.mindmed.co